Significant developments in ovarian, breast and lung cancer therapy Views & Reviews 05 February 2013 Pages: 3 - 5
New findings suggest novel approaches for prevention of miscarriage Newsletter Article 05 February 2013 Pages: 5 - 5
Antioxidants in atherosclerosis - getting on the right path Newsletter Article 05 February 2013 Pages: 6 - 6
Antidepressant use linked to greater healthcare consumption Newsletter Article 05 February 2013 Pages: 6 - 6
Financial and QOL impact of H. pylori eradication therapy Newsletter Article 05 February 2013 Pages: 7 - 7
Acellular pertussis vaccine a good candidate for widespread use Newsletter Article 05 February 2013 Pages: 8 - 8
Cytokine antagonism: still a main attraction in rheumatology R&D Gill Higgins Newsletter Article 05 February 2013 Pages: 9 - 10
Potential for progesterone in demyelinating diseases? Newsletter Article 05 February 2013 Pages: 11 - 11
Neurotrophin-4: a potential therapy for motor neuron diseases Newsletter Article 05 February 2013 Pages: 12 - 12
Interferon-α recommended for maintenance of multiple myeloma Newsletter Article 05 February 2013 Pages: 12 - 12
Treatment of NIDDM: current practice and new drug development Gill Higgins Newsletter Article 05 February 2013 Pages: 13 - 15
Early zidovudine therapy offers short-term benefits Newsletter Article 05 February 2013 Pages: 15 - 15
Gallstone prophylaxis withone ursodeoxycholic acid Newsletter Article 05 February 2013 Pages: 16 - 16
A breakthrough against adult T-cell leukaemia-lymphoma? Newsletter Article 05 February 2013 Pages: 16 - 16
Paclitaxel shows activity against Kaposi’s sarcoma Newsletter Article 05 February 2013 Pages: 18 - 18
Ketanserin has potential in hypertension in pregnancy Newsletter Article 05 February 2013 Pages: 19 - 19
Lowered GFR due to antihypertensive therapy reversible Newsletter Article 05 February 2013 Pages: 19 - 19
Longer action of vecuronium bromide in the elderly Newsletter Article 05 February 2013 Pages: 20 - 20
Heparin can cause aldosterone suppression and hyperkalaemia Newsletter Article 05 February 2013 Pages: 20 - 20
‘Excellent risk-benefit ratio’ with cisapride treatment Newsletter Article 05 February 2013 Pages: 21 - 21